Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 control
Mauro Malnati(Vita-Salute San Raffaele University), Roberto Biassoni(Istituto Giannina Gaslini), Angela Pistorio(Istituto Giannina Gaslini), Andrea De Maria(Ospedale Policlinico San Martino), Irene Vanni(Ospedale Policlinico San Martino), Guido Poli(University of Verona), Priscilla Biswas(Mario Negri Institute for Pharmacological Research), Francesca Sironi(Istituti di Ricovero e Cura a Carattere Scientifico), Maria Cristina Monti(University of Pavia), Davide De Battista(Vita-Salute San Raffaele University), Patrizia Larghero(Goethe University Frankfurt), Elisa Vicenzi(Mario Negri Institute for Pharmacological Research), Agostino Riva(ASST Fatebenefratelli Sacco), Silvia Nozza(IRCCS Ospedale San Raffaele), Giuseppe Tambussi(San Raffaele University of Rome), Elisabetta Ugolotti(Istituto Giannina Gaslini), Maciej Tarkowski(University of Milan), Gino Tripodi(Istituto Giannina Gaslini), Francesco Marras(Istituto Giannina Gaslini), Eddi Di Marco(Istituto Giannina Gaslini), Domenico Bordo(Ospedale Policlinico San Martino)
Cited by 26
Related Papers
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
|Nature Medicine|1997|635
Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains
|Immunity|1995|574
CD46 Is a Cellular Receptor for Human Herpesvirus 6
|Cell|1999|525